Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.45 is 12% above its 5-year average of -0.51, near the high end of its 5-year range (-0.60–-0.45).
12.62% above its 12-month average of -0.52.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.11.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 23 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.45
EARNINGS PER SHARE (EPS) AVG TTM
-0.52
EARNINGS PER SHARE (EPS) AVG 3Y
-0.50
EARNINGS PER SHARE (EPS) AVG 5Y
-0.51
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+12.62%
CURRENT VS 3Y AVG
+10.00%
CURRENT VS 5Y AVG
+12.05%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Nautilus Biotechnolgy, Inc.
Market Cap
$228.87M
Earnings Per Share (EPS)
-0.45
TTM Avg
-0.52
3Y Avg
-0.50
5Y Avg
-0.51
Market Cap
$227.24M
Earnings Per Share (EPS)
-0.22
TTM Avg
-1.13
3Y Avg
-1.09
5Y Avg
-1.70
Market Cap
$229.29M
Earnings Per Share (EPS)
-2.38
TTM Avg
-2.11
3Y Avg
-1.81
5Y Avg
-1.81
Market Cap
$227.03M
Earnings Per Share (EPS)
-3.17
TTM Avg
-5.64
3Y Avg
-13.77
5Y Avg
-18.37
Market Cap
$233.46M
Earnings Per Share (EPS)
-0.04
TTM Avg
0.58
3Y Avg
0.64
5Y Avg
0.70
Market Cap
$232.72M
Earnings Per Share (EPS)
-0.57
TTM Avg
-0.79
3Y Avg
-0.77
5Y Avg
-0.98
Market Cap
$220.57M
Earnings Per Share (EPS)
-0.99
TTM Avg
-1.25
3Y Avg
-1.31
5Y Avg
-1.33
Market Cap
$235.84M
Earnings Per Share (EPS)
3.28
TTM Avg
3.72
3Y Avg
4.14
5Y Avg
3.92
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nautilus Biotechnolgy, Inc. (NAUT) | $228.87M | -0.45 | -0.52 | -0.50 | -0.51 |
| MacroGenics, Inc. (MGNX)vs › | $227.24M | -0.22 | -1.13 | -1.09 | -1.70 |
| BioAge Labs Inc. (BIOA)vs › | $229.29M | -2.38 | -2.11 | -1.81 | -1.81 |
| Biodesix, Inc. (BDSX)vs › | $227.03M | -3.17 | -5.64 | -13.77 | -18.37 |
| Vogenx Inc. (VOGX)vs › | $225.93M | N/A | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $233.46M | -0.04 | 0.58 | 0.64 | 0.70 |
| InflaRx N.V. (IFRX)vs › | $232.72M | -0.57 | -0.79 | -0.77 | -0.98 |
| Profound Medical Corp. (PROF)vs › | $220.57M | -0.99 | -1.25 | -1.31 | -1.33 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.84M | 3.28 | 3.72 | 4.14 | 3.92 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.58M | -0.11 | -0.18 | -0.30 | -0.87 |
Trailing EPS (TTM)
$-0.45
Forward EPS (Est.)
$-0.51
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.47 |
| 2024-12-31 | -0.56 |
| 2023-12-31 | -0.51 |
| 2022-12-31 | -0.46 |
| 2021-12-31 | -0.60 |
| 2020-12-31 | -0.47 |
| 2019-12-31 | -1.59 |
| 2018-12-31 | 87.18 |
